Colonoscopic findings of symptomatic patients aged 50 to 80 years suggest that work-up of tumour suspicious symptoms hardly reduces colorectal cancer-induced mortality

Swiss Medical Weekly

Volumn 135, Issue 45-46, 2005, Pages 679-683

  Schoepfer, Alain ^a   Marbet, Urs A ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b Kantonsspital Uri   (Switzerland)

Author keywords

Adenomas; Advanced lesions; Colonoscopies; Colorectal cancer

Indexed keywords

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CANCER STAGING; COLONOSCOPY; COLORECTAL CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PAIN; PREDICTION; RETROSPECTIVE STUDY; RISK FACTOR; RISK REDUCTION; SCREENING TEST; SEX DIFFERENCE; SWITZERLAND; SYMPTOM;

EID: 29944447618     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. www.iarc.fr. International Agency for Research on Cancer. Cancer Incidence Data Bases. EUCAN 1997 (retrieved 16 January 2003).
2. Rozen P, Blanchard J, Campbell D, Carlsen E, Lambert R, Marbet U, et al. Implementing colorectal cancer screening: group 2 report. ESGE/UEGF colorectal cancer - public awareness campaign. The public/professional interface workshop: Oslo, Norway, June 20-22, 2003. Endoscopy 2004:36;354-8.
3. www.asrt.ch
4. Coughlin SS, Thompson TD. Colorectal cancer screening practices among men and women in rural and nonrural areas of the United States, 1999. J Rural Health 2004;20:118-24.
5. Winawer SJ, Fletcher RH, Miller L, Godlee F, Stolar MH, Mulrow CD, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 1997;122:594-642.
6. Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge JD, Ransohoff DF. Results of screening colonoscopy among persons 40 to 49 years of age. N Engl J Med 2002;346:1781-5.
7. U.S. Preventive Services Task Force. Screening for colorectal cancer: recommendation and rationale. Ann Intern Med 2002;137:129-31.
8. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993;328:1365-71.
9. Scholefield JH, Moss S, Sufi F, Mangham CM, Hardcastle JD. Effect of faecal occult blood screening on mortality from colorectal cancer: results from a randomised controlled trial. Gut 2002;50:840-4.
10. Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472-7.
11. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996;348:1467-71.
12. Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, et al. The effect of fecal occult blood screening on the incidence of colorectal cancer. N Engl J Med 2000;343:1603-7.
13. UK Flexible Sigmoidoscopy Screening Trial Investigators. Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial. Lancet 2002;359:1291-300.
14. Winawer SJ, Zauber AG, Ho MN, O'Brien MJ, Gottlieb LS, Sternberg SS, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The national polyp study workgroup. X Engl J Med 1993;329:2028-9.
15. Selby JV, Friedman GD, Quesenberry CP Jr, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992;326:653-7.
16. Betés M, Munoz-Navas MA, Duque JM, Angos R, Macias E, Subtil JC, et al. Use of colonoscopy as a primary screening test for colorectal cancer in average risk people. Am J Gastroenterol 2003;98:2648-54.
17. Newcomb PA, Storer BE, Morimoto LM, Templeton A, Potter JD. Long-term efficacy of sigmoidoscopy in the reduction of colorectal cancer incidence. J Natl Cancer Inst 2003;95:622-5.
18. www.bfs.admin.ch/bfs/portal/de/index/themen/bevoelkerung/ zukuenftge_bevoelkerungssentwicklung0/blank /szenarien/zentral/ur.html
19. Eide T. Risk of colorectal cancer in adenoma bearing individuals within a defined population. Int J Cancer 1986;38:173-6.
20. Gatta G, Capocaccia R, Sant M, Bell CM, Coebergh JW, Damhuis RA, et al. Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study. Gut 2000;47:533-8.
21. Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge JD, Ransohoff DF. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. NEJM 2000;343:169-74.
22. Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chejfec G. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med 2000;343:162-8.
23. Marbet UA, Bauerfeind P, Delco F, Dorta G, Meier R, Metzger U. Das Kolonkarzinom kann dank Screening verhütet werden. Schweiz Med Forum 2003;3:56-63.
24. http://www.fmh.ch/ww/de/pub/fmh/mitgliederstatistik/ fmh_rztestatistiken_1930_20/fmhaerztestastistik_2000.htm
25. Lagares-Garcia JA, Kurek S, Collier B, Diaz F, Schilli R, Richey J, Moore RA. Colonoscopy in octogenarians and older patients. Surg Endosc 2001;15:262-5.
26. Ure T, Dehghan K, Vernava AM 3rd, Longo WE, Andrus CA, Dan GL. Colonoscopy in the elderly. Low risk, high yield. Surg Endosc 1995;9:505-8.
27. Kotake K, Honjo S, Sugihara K, Kato T, Kodaira S, Takahashi T, et al. Changes in colorectal cancer during a 20-year period: an extended report from the multi-institutional registry of large bowel cancer, Japan. Dis Colon Rectum 2003;46:32-43.
28. Mc Cashland TM, Brand R, Lyden E, de Garmo P. Gender differences in colorectal polyps and tumours. Am J Gastroenterol 2001;96:882-6.
29. Okamoto M, Shiratori Y, Yama Y, Kato J, Togo G, Yoshida H, et al. Relationship between age and site of colorectal cancer based on colonoscopy findings. Gastrointest Endosc 2002;55:548-51.
30. Rex DK, Lehman GA, Ulbright TM, Smith JJ, Pound DK, Hawes RH. Colonic neoplasia in asymptomatic persons with negative fecal occult blood tests: Influence of age, gender and family history. Am J Gastroenterol 1993;88:825-31.
31. Khan A, Shrier I, Gordon PH. The changed histologic paradigm of colorectal polyps. Surg Endosc 2002;16:436-40.
32. Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge JD, Ransohoff DF. Using risk for advanced proximal neoplasia to tailor endoscopie screening for colorectal cancer. Ann Intern Med 2003;139:959-65.
33. Betés M, Munoz MA, Duque JM, Angos R, Macias E, Subtil JC, et al. Diagnostic value of distal colonic polyps for prediction of advanced proximal neoplasia in an average-risk population undergoing screening colonoscopy. Gastrointestinal Endoscopy 2004;59:634-41.
34. Gondal G, Grotmol T, Hofstad B, Bretthauer M, Eide TJ, Hoff G. Grading of distal colorectal adenomas as predictors for proximal colonic neoplasia and choice of endoscope in population screening: experience from the Norwegian Colorectal Cancer Prevention study (NORCCAP). Gut 2003;52:398-403.